"Medical quick reading society" pioneered the human trial of Johnson & Johnson new crown vaccine listed in Hong Kong

< br / > the drug administration of Shaanxi Province and the medical insurance bureau should jointly inspect the drugstores; Gao Lei, a senior manager of Harbin Pharmaceutical Co., Ltd., resigned; Yuandong biological science and technology innovation board passed the meeting; Xiansheng pharmaceutical went to Hong Kong for listing; another inactivated new crown vaccine developed by the Chinese team proved to be safe and effective in animals; saisheng pharmaceutical obtained the approval and registration of peptide inhibition produced by blood tubes for Injection..< br / > < br / > the drug administration of Shaanxi Province and the medical insurance bureau jointly printed and distributed the report on October 10 Notice on carrying out the special inspection of drugs in centralized purchase and use organized by the stateAccording to the requirements of the notice, Shaanxi Provincial Food and Drug Administration and its branches, provincial medical insurance bureau and municipal (District) medical insurance bureaus, in combination with the actual supervision of their respective jurisdictions, formulate special inspection work plans in accordance with the requirements of the notice to ensure the coverage and pertinence of special inspection work(Shaanxi food and Drug Administration) < br / > according to the official wechat of Nanjing Medical Insurance Bureau, Nanjing, Huai'an and Taizhou medical consumables Centralized Procurement Alliance expanded the scope of the alliance, and nine cities including Anqing, Chuzhou, Hefei, Huangshan, Maanshan, Tongling, Wuhu, Xuancheng and Zhenjiang joined the alliance, and Nanjing alliance expanded to 12 cities(Nanjing Medical Insurance Bureau) < br / > < br / > < br / / > AI Bowei and genmab jointly announced that they have reached extensive R & D cooperation to jointly develop three next-generation bispecific antibody products of genmab company, including its main candidate, epicortitamabAt the same time, the two companies will also cooperate to discover and develop other differential antibody anti-cancer therapiesAlberto will pay $750 million in upfront payments to genmab, with potential milestone payments of up to $3.15 billion(Wuxi apptec) < br / > Harbin Pharmaceutical Co., Ltdannounced that the board of directors of the company had received the resignation report from MrGao Lei, the deputy general manager of the company, and MrGao Lei resigned from the position of deputy general manager of the company due to personal reasonsAfter resignation, he did not hold any other positions in the companyAccording to the data, Gao Lei served as deputy general manager from September 13, 2018 to October 25, 2020(Sina Pharmaceutical News) < br / > according to the official website of science and Technology Innovation Board of Shanghai Stock Exchange, Chengdu Yuandong biopharmaceutical Co., Ltdhas successfully held a meeting, and the company plans to raise 1.161 billion yuan in science and technology innovation board(medicine magic cube) < br / > Xiansheng pharmaceutical industry submits the application for listing on the main board to the Hong Kong stock exchange, with Morgan Stanley and CICC as its co sponsorsFounded in 1995, Xiansheng pharmaceutical successfully landed in the US stock market on April 20, 2007 In 2014, Xiansheng pharmaceutical completed privatization and delisted from US stocks (magic medicine) < br / > bluesail medical released the announcement that bluesail new valve technology HK Limited, a wholly-owned subsidiary of the company and Hong Kong, has signed the delivery confirmation with NVT AG, a Swiss transcatheter aortic valve replacement (TAVR) company, and bluesail new valve technology HK Limited has become a shareholder directly holding 100% of the equity of NVT AG (gbihealth) < br / > on the 10th, Tianyan pharmaceutical announced that it has reached strategic cooperation with Tianbian research laboratory, a subsidiary of Tianbian Mitsubishi pharmaceutical TRL will develop a new generation of antibody coupled drugs for solid tumor targets by using safebody ®, an antibody precision masking technology independently developed by Tianyan pharmaceutical, and its unique cytotoxic loading technology The specific financial terms and target information of this cooperation have not been disclosed (Wuxi apptec) < br / > according to insiders, Pfizer announced that the three departments report directly to the president of Greater China The three business departments are: hospital sales business, retail business, innovative Internet medical service business (yaozhiwang) < br / > < br / > < br / / > Johnson & Johnson announced that it will accelerate the 1 / 2A human clinical trial of its new crown recombinant vaccine ad26.cov2-s through its Yang Sen Clinical trials, originally scheduled to begin in September, are now expected to begin in the second half of July (Wuxi apptec) < br / > Illumina announced that the FDA of the United States has granted the covidseq test emergency use authorization developed by the company This is a high-throughput, next-generation sequencing (NGS) - based workflow for in vitro diagnosis of coronavirus (IVD) This is the first ngs based new coronavirus diagnostic test authorized by FDA for emergency use (Wuxi apptec) < br / > aitebante acetate injection of Takeda has been applied for listing in China for the treatment of acute onset of hereditary angioedema in adults Hereditary angioedema (HAE) is a rare genetic disease, affecting about 1 / 10000-50000 people worldwide The disease is usually manifested in repeated edema of various parts of the body When edema occurs in the larynx, it may block the airway and lead to asphyxia (medicine magic cube) < br / > Sanofi recently announced the positive results of phase III ikema clinical trial of sarclisa (isatuximab), a CD38 targeted antibody drug, in the treatment of relapsed and / or refractory multiple myeloma (mm) The results showed that sarclisa + kafezomib + dexamethasone (s-kd) significantly reduced the risk of disease progression or death by 47% compared with kafezomib (kyrolis ®) + dexamethasone (s-kd), and showed clinically significant deep remission (negative rate of MRD: 29.6% vs 13%) (Biovalley) < br / > 10, BMS announced FDA approval of its new opdivo indication for the treatment of unresectable patients with advanced, recurrent or metastatic esophageal squamous cell carcinoma who had previously been treated with fluorouracil and platinum drugs This is the first immunotherapy approved to treat this group of patients, regardless of PD-L1 status (medicine magic cube) < br / > Bojian recently released the latest results of nurture research The nurture study is the longest study in patients with premenstrual spinal muscular atrophy (SMA) New data show that in infants genetically diagnosed with SMA, an unprecedented survival rate can be achieved after 4.8 years of early and sustained treatment with nosinogenase sodium injection Compared with the natural history, these patients maintained and acquired motor function continuously (AP) < br / > impl neuropharma today announced the positive results of the critical phase 3 clinical trial stop301 The study included 5650 patients with migraine attacks and evaluated the changes in migraine indicators reported by patients compared to the baseline The study reached the primary clinical end point (Wuxi apptec) < br / > saisheng Pharmaceutical Co., Ltd issued a notice on the 10th, saying that recently, the "anti peptide of angiogenesis for injection" developed by the company was reviewed and approved by the medical ethics committee (Sina Pharmaceutical News) < br / > according to the State Food and drug administration, the newly introduced contrast agent of Hengrui, iohexol injection, entered the "in approval" status in May and will soon be approved for listing At the same time, another contrast agent, iodophor injection, was approved for marketing one month ago (dingxiangyuan insight database) < br / > the State Food and Drug Administration announced that it would revise the instructions of vitamin B2 injection [adverse reactions] and [contraindications] On the same day, the instructions of sodium thiosulfate injection [adverse reactions] and [precautions] were revised (State Food and Drug Administration) < br / > cell, a top academic journal, published a new development of anti new coronavirus vaccine online A inactivated vaccine, bbibp-corv, developed by the Chinese research team, has been shown to be safe and effective in a number of animal experiments, including macaques This work was cooperated by Beijing Institute of Biological Products Co., Ltd., China Center for Disease Control and prevention, Chinese Academy of Medical Sciences, Peking Union Medical College, Tsinghua University and other units (yaomingkant) < br / > recently, the Chinese team of scientists Gao Guoquan, Zhongshan Medical College, Zhongshan University, published important research results on PNAS By analyzing the treatment data of thousands of patients with advanced colorectal cancer, they found that in patients with advanced colorectal cancer carrying KRAS mutation, compared with other types of hypoglycemic drugs, the total survival time of patients taking metformin was 37.8 months longer, and the median progression free survival time was 8.1 months longer (cypress blue)